Alstr�m Syndrome UK, England�s Rare Disease Delivery Group; UK Thalassaemia Society; Unique; Muscular Dystrophy UK; Genomics England, Association of the British Pharmaceutical Industry; Rare Diseases Industry Group; Orchard Therapeutics; Medical Research Council

Names in the records

Each spelling a register uses for this entity, and the method that tied it here. A name is never the identity; a similar name is never a match.

What the records establish

• Alstr�m Syndrome UK, England�s Rare Disease Delivery Group; UK Thalassaemia Society; Unique; Muscular Dystrophy UK; Genomics England, Association of the British Pharmaceutical Industry; Rare Diseases Industry Group; Orchard Therapeutics; Medical Research Council: 1 record of "recorded meeting with a minister" on 29 March 2022.

What this does not establish

The records above establish that Alstr�m Syndrome UK, England�s Rare Disease Delivery Group; UK Thalassaemia Society; Unique; Muscular Dystrophy UK; Genomics England, Association of the British Pharmaceutical Industry; Rare Diseases Industry Group; Orchard Therapeutics; Medical Research Council and each entity named appear together in an official register, in the relationship that register records, on the date it records. They do not establish why any donation was made, why any contract was awarded, whether any one record was known to the people behind another, or that any record caused another. No causal inference is made on this page, and nothing here is a finding of any kind against anyone. A reported donation is a lawful, reported transaction; a contract award is a published notice; a seat is a seat.